bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

Building Value From Various Perspectives – Strategy, Product Adoption & Sales Growth & IP Protection

by Maria Zannes | May 10, 2016 | Events

May 10, 2016 @2:15 pm- 3:00 pm   InnoTech Emerging Medical Technology Symposium Session Two Panelist:  Maria Zannes   Henry B Gonzalez Convention Center San Antonio, TXUnited States   

A Porphyrin-Based Assay to Detect Early Stage Lung Cancer in Sputum

by Maria Zannes | Apr 16, 2016 | Events

April 16, 2016-April 17, 2016   Presenter:  Vivienne Rebel, MD, PhD Associate Professor, Department of Cellular and Structural Biology, Health Science Center in San Antonio, San Antonio, TX, United States of America   Abstract: The overall 5-year survival...

SA biotech firm accelerating commercialization plan with more science expertise

by Maria Zannes | Apr 9, 2016 | News

APRIL 9, 2016 As published in the San Antonio Business Journal By W. Scott Bailey San Antonio based bioAffinity Technologies is moving closer to commercializing its initial cancer diagnostics technology via a combination of new funding and strategic hires, according...

bioAffinity Technologies aims to take the worry out of early-stage lung cancer screening

by Maria Zannes | Apr 6, 2016 | News

APRIL 6, 2016 As published in the San Antonio Express News By Peggy O’Hare, Staff Writer The problem with early lung cancer screening is the unnecessary worry for the 97 percent of patients flagged with suspicious results — that ultimately turn out to be inaccurate....

bioAffinity Technologies Appoints New Science Team

by Maria Zannes | Apr 4, 2016 | Press Releases

APRIL 4, 2016 (SAN ANTONIO, TX) bioAffinity Technologies, a privately held cancer diagnostics company, today announced that Vivienne Rebel, M.D., Ph.D., has joined the Company as Executive Vice President of Research and Development (R&D) and Chief Medical and...
« Older Entries
Next Entries »

Categories

  • Articles (27)
  • Events (38)
  • News (52)
  • Press Releases (128)
  • Publications (17)

Recent Posts

  • bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic July 15, 2025
  • Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging July 9, 2025
  • bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference June 26, 2025
  • bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy June 24, 2025
  • bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board June 11, 2025

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.